FINISHED DOSAGE FORMULATIONS
SUCRALOSE
Route : BUCCAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 3.5
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : NASAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 0.15
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : NASAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 0.15
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 5.5
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 5.4
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 2.33
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 1
Potency Unit : MG/1ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 1210
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 90
Potency Unit : MG/1PKT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 34.25
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
03 May 2021
Reply
19 Jul 2017
Reply
25 Jul 2025
Reply
10 Jul 2025
Reply
19 Jun 2025
Reply
27 May 2025
Reply
22 Apr 2025
Reply
25 Mar 2025
Reply
10 Feb 2025
Reply
15 Feb 2024
Reply
21 Dec 2023
Reply
31 May 2023
REF. STANDARDS & IMPURITIES